Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trialVolker Kunzmann, Wolfgang Blau, Jens T. Siveke et al.|The Lancet. Gastroenterology & hepatology|2020Cited by 202
A prospective observational study of real-world treatment and outcome in secondary CNS lymphomaStefan Habringer, Ulrich Keller, Roland Schroers et al.|European Journal of Cancer|2023Cited by 8